Despite the established role of inflammasome pathway in the orchestration of an inflammatory response, through release of pro-inflammatory cytokines IL-1β and IL-18, its role in cancer development, progression, and immunotherapy response remains contradictive. This evidence concerns the gene IL1B and cancer.